Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (799)	12/30/2001 10:15:01 PM
From: scaram(o)uche	Respond to of 2243

right on the money with Peter & tuck. Thanks. Think of this year's winners in this fashion??..... Biotech has four types of companies: 1. Big-science companies with sincere, enlightened management; 2. License boutiques or limited-science companies with at least one good product candidate and enlightened and/or sincere management; 3. Sincere efforts with decent science and clueless management; and 4. Scams. SI Biotech has played a pretty decent role in directing investment dollars away from the latter two types of companies and into the class acts. We can be -- and have often been -- a very visible filter. Our loudest voices therefore play a supportive role for the best of bench scientists, accelerating medical research. Peter and Tuck have the guts to collect relevant information and make very public calls. Portfolio "2000" broke $500K on Friday, up 401% to date. Maybe Imclone sellers will head for small caps, and it'll hold that milestone over the last few hours of trading for the year........ siliconinvestor.com